Obstetrics & Gynecology · New York, NY
NPI
1558362210
Since 2005
Specialty
Obstetrics & Gynecology
Code 207V00000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
314 E 34th St Fl 5
New York, NY, 10016
Phone (212) 717-5554
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$153K
730 prescriptions
Company payments, 2025
$73K
From 7 companies
Medicare prescription drug claims, 2024
In 2024, the drug Steven R Goldstein prescribed most often to Medicare patients was Estradiol, with 135 prescriptions and refills. In total Steven R Goldstein wrote 730 Medicare prescriptions that cost $153K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-04-10.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Estradiol Generic | 135 | 347 | 52 | $15K |
| Raloxifene Hcl Generic | 86 | 257 | 28 | $5,404 |
| Duavee Estrogens,conj/Bazedoxifene | 47 | 129 | 14 | $24K |
| Osphena Ospemifene | 46 | 106 | 15 | $25K |
| Premarin Estrogens, Conjugated | 46 | 123 | 17 | $21K |
| Yuvafem Estradiol | 42 | 103 | 15 | $8,689 |
| Progesterone Progesterone, Micronized | 38 | 73 | Under 11 | $794 |
| Estradiol-Norethindrone Acetat Estradiol/Norethindrone Acet | 22 | 45 | Under 11 | $1,003 |
| Betamethasone Valerate Generic | 20 | 22 | 16 | $592 |
| Vagifem Estradiol | 19 | 51 | Under 11 | $9,117 |
| Fluconazole Generic | 17 | 17 | Under 11 | $69.24 |
| Dotti Estradiol | 17 | 40 | Under 11 | $2,192 |
| Evista Raloxifene Hcl | 15 | 33 | Under 11 | $6,547 |
| Medroxyprogesterone Acetate Generic | 14 | 22 | Under 11 | $60.08 |
| Estring Estradiol | 14 | 42 | Under 11 | $7,397 |
Brand drugs: 228 claims; generic drugs: 502 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Steven R Goldstein $73K ($42K in general payments such as food, travel and fees and $30K for research) from 7 companies. The largest payer was Bayer Healthcare Pharmaceuticals Inc. with $27K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.